01839nam 2200457 450 991069952240332120230902161604.0(CKB)5470000002403705(OCoLC)1259439473(EXLCZ)99547000000240370520210708d2010 ua 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierPotential health & safety impacts from pharmaceuticals and supplements containing Chinese-sourced raw ingredients[Washington, D.C.] :U.S.-China Economic and Security Review Commission,2010.1 online resource (ii, 65 pages) color illustrations"Prepared for U.S. China Economic and Security Review Commission.""NSD Bio Group, LLC.""April 2010."Includes bibliographical references.Potential health and safety impacts from pharmaceuticals and supplements containing Chinese-sourced raw ingredientsRaw materialsChinaDrugsStandardsUnited StatesDietary supplementsStandardsUnited StatesPharmaceutical industryUnited StatesQuality controlDrug factoriesChinaQuality controlRaw materialsDrugsStandardsDietary supplementsStandardsPharmaceutical industryQuality control.Drug factoriesQuality control.U.S.-China Economic and Security Review Commission,GPOGPOBOOK9910699522403321Potential health & safety impacts from pharmaceuticals and supplements containing Chinese-sourced raw ingredients3104198UNINA